Avasopasem for the treatment of radiotherapy-induced severe oral mucositis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Avasopasem for the treatment of radiotherapy-induced severe oral mucositis

Published:2023-06-03 Issue:6 Volume:32 Page:463-470
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Sonis Stephen T.¹²,Anderson Carryn M.³

Affiliation:

1. Divisions of Oral Medicine, Brigham and Women’s Hospital and the Dana-Farber Cancer Institute, Boston, MA, USA

2. Biomodels, LLC and Primary Endpoint Solutions, LLC, Waltham, MA, USA

3. Department of Radiation Oncology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2023.2230117

Reference42 articles.

1. NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022

2. Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salivary DNA methylation derived estimates of biological aging, cellular frequency and protein expression as predictors of oral mucositis severity and survival in head and neck cancer patients;Oral Oncology;2024-12

2. The Pivotal Role of Preclinical Animal Models in Anti-Cancer Drug Discovery and Personalized Cancer Therapy Strategies;Pharmaceuticals;2024-08-09

3. Comparisons of successful and failed Phase III trials of drugs and biologicals tested for mitigation of oral mucositis in patients being treated with radiotherapy with or without concomitant chemotherapy for cancers of the head and neck;Drug Development Research;2024-04-28

4. Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents;Expert Opinion on Pharmacotherapy;2024-04-12

5. Superoxide Dismutase and Catalase;Reference Module in Biomedical Sciences;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3